Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Linda Llewelyn is Chief People Officer at Health Catalyst. OQRO lists 11 transactions filed with the SEC under this name, the latest on Jun 4, 2026, each linked to the official Form 4.
Chief People Officer
Disclosures on record
11
Companies involved
1
As of the latest filing on , Linda Llewelyn reported holding 321,132 shares of Health Catalyst (HCAT), worth about $485K at the last close of $2 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Health Catalyst HCAT | 321,132 | 321K direct | $2 | $485K | Jun 1, 2026 |
Is this Linda Llewelyn’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Health CatalystHCAT
11 disclosures · Oct 2024 – Jun 2026 · 5 sold
Jun 1, 20268,519disclosed Jun 4
DetailsOfficial recordMar 2, 202614Kdisclosed Mar 6
DetailsOfficial recordFeb 25, 2026192Kdisclosed Feb 28
DetailsOfficial recordFeb 25, 202613Kdisclosed Feb 28
DetailsOfficial recordFeb 26, 20264,471disclosed Feb 28
DetailsOfficial recordDec 1, 20259,762disclosed Dec 4
DetailsOfficial recordFeb 18, 2025Sold~$35Kdisclosed Feb 21
DetailsOfficial recordJan 15, 2025Sold~$37Kdisclosed Jan 18
DetailsOfficial recordDec 16, 2024Sold~$51Kdisclosed Dec 18
DetailsOfficial recordNov 15, 2024Sold~$12Kdisclosed Nov 18
DetailsOfficial recordOct 15, 2024Sold~$11Kdisclosed Oct 17
DetailsOfficial recordLinda Llewelyn has no open-market purchase on record since 2020. Sales in each of the last 6 years.
Linda Llewelyn reported 0 open-market purchases and 83 sales since 2020; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $72K2×2 trades |
| 2024 | — | $218K12×12 trades |
| 2023 | — | $86K7×7 trades |
| 2022 | — | $342K14×14 trades |
| 2021 | — | $1.82M23×23 trades |
| 2020 | — | $1.2M25×25 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Jun 1, 2026, Linda Llewelyn reported holding 321,132 shares of Health Catalyst (HCAT). At the last close of $2 on Nov 13, 2026, that is about $485K. This is the stake disclosed in filings, not a net worth.
Linda Llewelyn has no open-market purchase on record since 2020. Sales in each of the last 6 years.
In SEC filings since 2020: no open-market purchase is on record; the latest open-market sale is from 2025.
Health Catalyst (HCAT), from 2020 to 2025: 0 purchases and 83 sales.
Linda Llewelyn reported 0 open-market purchases and 83 sales here, 2020 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
